恒瑞医药(01276.HK)10月17日耗资2557.68万元回购39.26万股A股
Ge Long Hui·2025-10-17 08:48

Group 1 - The company, Heng Rui Medicine, announced a share buyback plan on October 17, 2025, involving an expenditure of RMB 25.5768 million to repurchase 392,600 A-shares [1] - The repurchase price per share is set between RMB 65 and RMB 65.41 [1]